A Bi-Adjuvant Nanovaccine That Potentiates Immunogenicity of Neoantigen for Combination Immunotherapy of Colorectal Cancer

Science advances - United States
doi 10.1126/sciadv.aaw6071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Tumor Neoantigen Heterogeneity Thresholds Provide a Time Window for Combination Immunotherapy

2019English

Adjuvant Chemotherapy of Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
1996English

Adjuvant Treatment of Colorectal Cancer

Acta chirurgica iugoslavica
2002English

Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine

PLoS ONE
Multidisciplinary
2014English

Adjunct Therapy During Combination Chemotherapy for Colorectal Cancer

Onkologiya. Zhurnal imeni P.A.Gertsena
2016English

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-Priming and Check-Point Inhibitor Blockade Are Required for Immunotherapy

Proceedings of the Japan Academy Series B: Physical and Biological Sciences
MultidisciplinaryBiological SciencesMedicineAgriculturalAstronomyPhysics
2018English

Vaccine Immunotherapy Strategies in Colorectal Cancer Treatment

Single Cell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy